Overview
Haeyoung Lee practices practicing medicine in Busan, Republic of Korea.
Their clinical expertise encompasses Cavernous Lymphangioma, COVID-19, Laryngeal Cancer, and Throat Cancer.
They are actively involved in clinical research, co-authoring 11 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Haeyoung Lee
Is Haeyoung Lee a top-rated expert for Cavernous Lymphangioma?
MediFind is an objective health platform that identifies experts based on real-world data. Haeyoung Lee is classified as an Experienced expert for Cavernous Lymphangioma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Haeyoung Lee participate in research or clinical trials?
Yes. Haeyoung Lee has published 11 articles and abstracts on conditions like Cavernous Lymphangioma. You can view a list of Haeyoung Lee's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Cavernous LymphangiomaLee isExperienced. Learn about Cavernous Lymphangioma.
- COVID-19Lee isExperienced. Learn about COVID-19.
- Laryngeal CancerLee isExperienced. Learn about Laryngeal Cancer.
- Throat CancerLee isExperienced. Learn about Throat Cancer.